Abstract: Methods for reducing the formation of impurities in finished dosage forms of anamorelin hydrochloride, including formulations for improving such stability and analytical techniques for controlling impurity formation.

Abstract: Provided is a method of manufacturing a microbially produced plastic having low coloration, good tone, and low odor, based on a simple, low-cost method that is suitable for industrial production. The method of manufacturing the microbially produced plastic is characterized in that a step (a) and a step (b), described below, are included: step (a) is a step of applying heat treatment to fat containing hydrogen peroxide, and step (b) is a step of culturing microbes in a culturing liquid containing the fat that has been subjected to the heat treatment in the step (a).

Abstract: The objective of the present invention is to provide a method for easily and efficiently producing cellulose beads which have pore shape suitable for an adsorbent and of which adsorption performance is excellent without using highly toxic and highly corrosive auxiliary raw material and without industrially disadvantageous cumbersome step. The method for producing porous cellulose beads according to the present invention is characterized in comprising (a) the step of preparing a fine cellulose dispersion by mixing a low temperature alkaline aqueous solution and cellulose, (b) the step of preparing a mixed liquid by adding a crosslinking agent to the fine cellulose dispersion, (c) the step of preparing an emulsion by dispersing the mixed liquid in a dispersion medium, (d) the step of contacting the emulsion with a coagulating solvent.

Abstract: Provided is a method of manufacturing a microbially produced plastic having low coloration, good tone, and low odor, based on a simple, low-cost method that is suitable for industrial production. The method of manufacturing the microbially produced plastic is characterized in that a step (a) and a step (b), described below, are included: step (a) is a step of applying heat treatment to fat containing hydrogen peroxide, and step (b) is a step of culturing microbes in a culturing liquid containing the fat that has been subjected to the heat treatment in the step (a).

Abstract: A method for producing porous cellulose beads includes preparing a fine cellulose dispersion by mixing a low temperature alkaline aqueous solution and cellulose; preparing a mixed liquid by adding a crosslinking agent to the fine cellulose dispersion; preparing an emulsion by dispersing the mixed liquid in a dispersion medium; and contacting the emulsion with a coagulating solvent.

Abstract: The objective of the present invention is to provide a method for easily and efficiently producing cellulose beads which have pore shape suitable for an adsorbent and of which adsorption performance is excellent without using highly toxic and highly corrosive auxiliary raw material and without industrially disadvantageous cumbersome step. The method for producing porous cellulose beads according to the present invention is characterized in comprising (a) the step of preparing a fine cellulose dispersion by mixing a low temperature alkaline aqueous solution and cellulose, (b) the step of preparing a mixed liquid by adding a crosslinking agent to the fine cellulose dispersion, (c) the step of preparing an emulsion by dispersing the mixed liquid in a dispersion medium, (d) the step of contacting the emulsion with a coagulating solvent.

Abstract: The invention provides a novel cerebral stroke recurrence inhibitor, and relates to a simple evaluation method for an cerebral stroke recurrence inhibitor. According to the simple evaluation method using stroke-prone spontaneously hypertensive (SHR-SP) rats, which has been established by the present inventors, it has been confirmed that atorvastatin is effective for preventing cerebral stroke recurrence, for relieving cerebral stroke recurrence-accompanied neurologic symptoms, and for improving survival rate after onset of the stroke. Accordingly, atorvastatin is useful as an cerebral stroke recurrence inhibitor.